Lyly Annina, von Schantz Carina, Salonen Tarja, Kopra Outi, Saarela Jani, Jauhiainen Matti, Kyttälä Aija, Jalanko Anu
Department of Molecular Medicine, National Public Health Institute, Biomedicum Helsinki, Haartmaninkatu 8, Helsinki, Finland.
BMC Cell Biol. 2007 Jun 12;8:22. doi: 10.1186/1471-2121-8-22.
Neuronal ceroid lipofuscinoses (NCLs) are collectively the most common type of recessively inherited childhood encephalopathies. The most severe form of NCL, infantile neuronal ceroid lipofuscinosis (INCL), is caused by mutations in the CLN1 gene, resulting in a deficiency of the lysosomal enzyme, palmitoyl protein thioesterase 1 (PPT1). The deficiency of PPT1 causes a specific death of neocortical neurons by a mechanism, which is currently unclear. To understand the function of PPT1 in more detail, we have further analyzed the basic properties of the protein, especially focusing on possible differences in non-neuronal and neuronal cells.
Our study shows that the N-glycosylation of N197 and N232, but not N212, is essential for PPT1's activity and intracellular transport. Deglycosylation of overexpressed PPT1 produced in neurons and fibroblasts demonstrates differentially modified PPT1 in different cell types. Furthermore, antibody internalization assays showed differences in PPT1 transport when compared with a thoroughly characterized lysosomal enzyme aspartylglucosaminidase (AGA), an important observation potentially influencing therapeutic strategies. PPT1 was also demonstrated to form oligomers by size-exclusion chromatography and co-immunoprecipitation assays. Finally, the consequences of disease mutations were analyzed in the perspective of our new results, suggesting that the mutations increase both the degree of glycosylation of PPT1 and its ability to form complexes.
Our current study describes novel properties for PPT1. We observe differences in PPT1 processing and trafficking in neuronal and non-neuronal cells, and describe for the first time the ability of PPT1 to form complexes. Understanding the basic characteristics of PPT1 is fundamental in order to clarify the molecular pathogenesis behind neurodegeneration in INCL.
神经元蜡样脂褐质沉积症(NCLs)是最常见的一类隐性遗传性儿童脑病。NCL最严重的形式,婴儿型神经元蜡样脂褐质沉积症(INCL),是由CLN1基因突变引起的,导致溶酶体酶棕榈酰蛋白硫酯酶1(PPT1)缺乏。PPT1缺乏通过一种目前尚不清楚的机制导致新皮质神经元特异性死亡。为了更详细地了解PPT1的功能,我们进一步分析了该蛋白的基本特性,尤其关注非神经元细胞和神经元细胞中可能存在的差异。
我们的研究表明,N197和N232的N-糖基化而非N212的N-糖基化对PPT1的活性和细胞内运输至关重要。对神经元和成纤维细胞中过表达的PPT1进行去糖基化处理,结果表明不同细胞类型中PPT1的修饰存在差异。此外,抗体内化试验显示,与一种已被充分表征的溶酶体酶天冬氨酰葡糖胺酶(AGA)相比,PPT1的运输存在差异,这一重要发现可能会影响治疗策略。通过尺寸排阻色谱法和免疫共沉淀试验还证明PPT1会形成寡聚体。最后,根据我们的新结果分析了疾病突变的后果,表明这些突变增加了PPT1的糖基化程度及其形成复合物的能力。
我们目前的研究描述了PPT1的新特性。我们观察到PPT1在神经元细胞和非神经元细胞中的加工和运输存在差异,并首次描述了PPT1形成复合物的能力。了解PPT1的基本特征对于阐明INCL神经退行性变背后的分子发病机制至关重要。